David L. Nelson

1.1k citations

23 papers · 852 indexed · h-index 17

Cellular and Molecular Neuroscience top 5%
Molecular Biology
Organic Chemistry top 10%
Clinical Psychology top 10%
Toxicology top 2%

Co-authors: David B. Wainscott Virginia L. Lucaites David E. Nichols Danuta Marona‐Lewicka Aaron Monte Richard A. Glennon Matthew Parker Jonathan D. Kursar
Topics: Neurotransmitter Receptor Influence on Behavior (14 papers)Psychedelics and Drug Studies (6 papers)Neuroscience and Neuropharmacology Research (5 papers)
Cited by: Toxicology Cellular and Molecular Neuroscience Organic Chemistry
Journals: Journal of the American Chemical Society Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States United Kingdom Sweden

In The Last Decade

David L. Nelson

23 papers receiving 811 citations

Peers

Countries citing papers authored by David L. Nelson

Since Specialization

Citations

This map shows the geographic impact of David L. Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Nelson more than expected).

Fields of papers citing papers by David L. Nelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Nelson. The network helps show where David L. Nelson may publish in the future.

Co-authorship network of co-authors of David L. Nelson

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Nelson. A scholar is included among the top collaborators of David L. Nelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Nelson. David L. Nelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In Vitro and in Vivo Evidence for a Lack of Interaction with Dopamine D2 Receptors by the Metabotropic Glutamate 2/3 Receptor Agonists 1S,2S,5R,6S-2-Aminobicyclo[3.1.0]hexane-2,6-bicaroxylate Monohydrate (LY354740) and (−)-2-Oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic Acid (LY379268) 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Matthew Fell,Kenneth W. Perry,Julie F. Falcone,Bryan G. Johnson,Vanessa Barth,Karen Rash,Virginia L. Lucaites,Penny G. Threlkeld,James A. Monn,David L. McKinzie,Gerard J. Marek,Kjell Svensson,David L. Nelson	31
2	Indoloxypropanolamine analogues as 5-HT1A receptor antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Joseph H. Krushinski,John M. Schaus,(unknown),David O. Calligaro,David L. Nelson,(unknown),David B. Wainscott,David T. Wong	10
3	Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·Deyi Zhang,(unknown),Joseph H. Krushinski,Sidney Liang,Bai‐Ping Ying,(unknown),Sean R. Dinn,David B. Wainscott,(unknown),Wendy H. Gough,David L. Nelson,John M. Schaus,Yao‐Chang Xu	15
4	Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4 2004 ·Bioorganic & Medicinal Chemistry Letters ·Vincent P. Rocco,(unknown),Todd J. Kohn,(unknown),David L. Nelson,David B. Wainscott,(unknown),Janice Shaw,Penny G. Threlkeld,David T. Wong,Kumiko Takeuchi	30
5	Substituted furo[3,2-b]pyridines: novel bioisosteres of 5-HT1F receptor agonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Brian M. Mathes,(unknown),John M. Schaus,Yao‐Chang Xu,David L. Nelson,David B. Wainscott,(unknown),Wendy H. Gough,Theresa A. Branchek,John M. Zgombick,Sandra Filla	9
6	Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1 2003 ·Bioorganic & Medicinal Chemistry Letters ·Kumiko Takeuchi,Todd J. Kohn,(unknown),Vincent P. Rocco,(unknown),Daniel J. Koch,David L. Nelson,David B. Wainscott,(unknown),Janice Shaw,Penny G. Threlkeld,David T. Wong	45
7	Advances Toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 2 2003 ·Bioorganic & Medicinal Chemistry Letters ·Kumiko Takeuchi,Todd J. Kohn,(unknown),Vincent P. Rocco,(unknown),Daniel J. Koch,(unknown),Larry W. Hertel,David L. Nelson,David B. Wainscott,(unknown),Janice Shaw,Penny G. Threlkeld,David T. Wong	20
8	In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT1B/1D/2 receptor antagonist properties 2001 ·European Journal of Pharmacology ·Ian A. Pullar,John R. Boot,Stephen Carney,Marlene L. Cohen,(unknown),Richard G. Conway,(unknown),Virginia L. Lucaites,David L. Nelson,Kathryn W. Schenck,Rosemarie Tomlinson,(unknown)	11
9	LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine2A receptor antagonist: a comparison with the antidepressant, nefazodone 2000 ·European Journal of Pharmacology ·Ian A. Pullar,Stephen Carney,(unknown),Virginia L. Lucaites,David L. Nelson,(unknown)	44
10	Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors 1999 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·David L. Nelson,Virginia L. Lucaites,David B. Wainscott,Richard A. Glennon	106
11	Thieno[3,2-b]- and Thieno[2,3-b]pyrrole Bioisosteric Analogues of the Hallucinogen and Serotonin Agonist N,N-Dimethyltryptamine 1999 ·Journal of Medicinal Chemistry ·(unknown),Danuta Marona‐Lewicka,Arthi Kanthasamy,Virginia L. Lucaites,David L. Nelson,David E. Nichols	49
12	A Novel (Benzodifuranyl)aminoalkane with Extremely Potent Activity at the 5-HT_2A Receptor 1998 ·Journal of Medicinal Chemistry ·Matthew Parker,Danuta Marona‐Lewicka,Virginia L. Lucaites,David L. Nelson,David E. Nichols	59
13	Synthesis and Serotonin Receptor Affinities of a Series of trans-2-(Indol-3-yl)cyclopropylamine Derivatives 1998 ·Journal of Medicinal Chemistry ·Suwanna Vangveravong,Arthi Kanthasamy,Virginia L. Lucaites,David L. Nelson,David E. Nichols	21
14	Dihydrobenzofuran Analogues of Hallucinogens. 4. Mescaline Derivatives 1997 ·Journal of Medicinal Chemistry ·Aaron Monte,(unknown),Danuta Marona‐Lewicka,David B. Wainscott,David L. Nelson,Elaine Sanders‐Bush,David E. Nichols	70
15	Dihydrobenzofuran Analogues of Hallucinogens. 3. Models of 4-Substituted (2,5-Dimethoxyphenyl)alkylamine Derivatives with Rigidified Methoxy Groups 1996 ·Journal of Medicinal Chemistry ·Aaron Monte,Danuta Marona‐Lewicka,Matthew Parker,David B. Wainscott,David L. Nelson,David E. Nichols	90
16	Synthesis of Some 5-Substituted Indoles 1992 ·Heterocycles ·Arnold R. Martin,Youhua Yang,David L. Nelson,(unknown)	19
17	A 3 dimensional model for 5-HT1A-receptor agonists based on stereoselective methyl-substituted and conformationally restricted analogs of 8-hydroxy-2-(dipropylamino)tetralin 1991 ·Journal of Medicinal Chemistry ·Charlotta Mellin,(unknown),David L. Nelson,(unknown),Hong Yu,(unknown),I. CSOEREGH,L.‐E. ARVIDSSON,Uli Hacksell	55
18	Serotonergic properties of spiroxatrine enantiomers 1988 ·Journal of Medicinal Chemistry ·Sham S. Nikam,Arnold R. Martin,David L. Nelson	28
19	Electronic effects in the interaction of para-substituted benzamidines with trypsin: the involvement of the .pi.-electronic density at the central atom of the substituent in binding 1977 ·Journal of the American Chemical Society ·Marcos Mares-Guia,David L. Nelson,(unknown)	25
20	Methylseleno derivatives of phosphorous and arsenic 1975 ·Inorganic and Nuclear Chemistry Letters ·John W. Anderson,John E. Drake,Raymond T. Hemmings,David L. Nelson	3

About David L. Nelson

David L. Nelson is a scholar working on Cellular and Molecular Neuroscience, Organic Chemistry and Clinical Psychology, having authored 23 papers that have together received 852 indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (14 papers), Psychedelics and Drug Studies (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). The work is most often cited by research in Toxicology (98 citations), Cellular and Molecular Neuroscience (443 citations) and Organic Chemistry (318 citations). David L. Nelson has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include David B. Wainscott, Virginia L. Lucaites, David E. Nichols, Danuta Marona‐Lewicka, Aaron Monte, Richard A. Glennon, Matthew Parker, Jonathan D. Kursar, M Baez and Arnold R. Martin. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact